Premature speculation about the end of PMS
The headline in the Independent “It’s official: A small dose of Prozac can help beat PMS” may be true if you are a rat but is slightly premature if you are a woman.
Research conducted by Dr Thelma Lovick and her team at University of Birming has idenitified the role of a neurosteroid, allopregnanolone (Allo) in premenstrual syndrome (PMS).
Following years of dispute about PMS, Lovick claims to have found an organic cause for the problem that blights the lives of millions of women.
Developing in many women the week before their menstrual period, common symptoms of PMS include psychological changes such as anxiety, mood swings, tiredness, irritability, depression, a loss in confidence and clumsiness.
Physical changes such as headaches, feeling bloated, altered appetite, joint pain and breast tenderness may also be experienced.
In a study on rats, a fall in the steroid Allo has been identified as the cause of premenstrual-like symptoms. The symptoms were alleviated by a small dose of the anti-depressant fluoxetine, commonly known as Prozac.
Dr Lovick stated ‘The time is right for a controlled clinical trial in women. The solution to PMS could be as simple as taking a pill for a few days towards the ends of your menstrual cycle.”
This is good news for sufferers of PMS but Lovick’s research, due to be published this autumn, is pointing a way forward for further research rather than pronouncing PMS cured.
Human trials have yet to be conducted and any real solution for women may be several years away. Prozac is not licensed in the UK to treat PMS and there have been side effects related to the use of anti-depressants like Prozac.
The press release from Lovick and her team make much of this clear, as does the detail below the headline in the Independent. But its’s not ‘official’ and its not yet been proved.
Read the press release from University of Birmingham and the full story in The Independent.











